Design and methodology of the Occluded Artery Trial (OAT)

American Heart Journal

Volumn 150, Issue 4, 2005, Pages 627-642

  Hochman, Judith S ^a   Lamas, Gervasio A ^a   Knatterud, Genell L ^a   Buller, Christopher E ^a   Dzavik, Vladimir ^a   Mark, Daniel B ^a   Reynolds, Harmony R ^a   White, Harvey D ^a  

^a HCC 1173 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; STENTS;

EID: 25844501925     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.07.002     Document Type: Article

References (49)

1. W.J. Rogers, J.G. Canto, and C.T. Lambrew Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3 J Am Coll Cardiol 36 2000 2056 2063
2. LATE Investigators Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction Lancet 342 1993 759 766
3. EMERAS (Estudio Multicentro Estreptoquinasa Republicas de America del Sur) Collaborative Group Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction Lancet 342 1993 767 772
4. M.E. Bertrand, J.M. Lefevbre, and M.F. Rousseau Coronary arteriography in acute transmural myocardial infarction Am Heart J 97 1979 61
5. M.A. DeWood, J. Spores, and R. Notske Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction N Engl J Med 303 1980 897 902
6. R.A. Kerensky, M. Wade, and P. Deedwania Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory J Am Coll Cardiol 39 2002 1456 1463
7. D.R. Ferry, R.A. O'Rourke, and A.S. Blaustein Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators J Am Coll Cardiol 31 1998 312 320
8. T.J. Ryan, E.M. Antman, and N.H. Brooks 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 34 1999 890 911
9. S. Sadanandan, C. Buller, and V. Menon The late open artery hypothesis-a decade later Am Heart J 142 2001 411 421
10. A.K. Berger, E.W. Edris, and J.A. Breall Resource use and quality of care for Medicare patients with acute myocardial infarction in Maryland and the District of Columbia: analysis of data from the Cooperative Cardiovascular Project Am Heart J 135 1998 349 356
11. E. Guadagnoli, P.J. Hauptman, and J.Z. Ayanian Variation in the use of cardiac procedures after acute myocardial infarction N Engl J Med 333 1995 573 578
12. L. Pilote, R.M. Califf, and S. Sapp Regional variation across the United States in the management of acute myocardial infarction N Engl J Med 333 1995 565 572
13. K.A. Fox, S.G. Goodman, and F.A. Anderson Jr. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes Eur Heart J 24 2003 1414 1424
14. F. Van de Werf, E.J. Topol, and K.L. Lee Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial JAMA 273 1995 1586 1591
15. J.L. Rouleau, L.A. Moye, and M.A. Pfeffer A comparison of management patterns after acute myocardial infarction in Canada and the United States N Engl J Med 328 1993 784 799
16. H.D. White, D.B. Cross, and J.M. Elliott Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction Circulation 89 1994 61 67
17. J.A. Puma, M.H. Sketch Jr., and T.D. Thompson Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy Am J Cardiol 83 1999 482 487
18. M.G. Franzosi, E. Santoro, and C. De Vita Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction Circulation 98 1998 2659 2665
19. C. Baigent, R. Collins, and P. Appleby ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither BMJ 316 1998 1337 1343
20. R.M. Califf, E.J. Topol, and B.J. Gersh From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapy J Am Coll Cardiol 14 1989 1382 1388
21. L.D. Hillis, and R.A. Lange Time for a randomized trial of the "open artery hypothesis" in survivors of acute myocardial infarction Am J Cardiol 69 1992 1359 1360
22. C.B. Kim, and E. Braunwald Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis Circulation 88 1993 2426 2436
23. J.S. Hochman Has the time come to seek and open all occluded infarct related arteries after myocardial infarction? J Am Coll Cardiol 28 1996 846 848
24. H.D. White Should all occluded infarct-related arteries be opened? Eur Heart J 18 1997 1207 1209
25. V. Mathew, and B.J. Gersh To open or not to open: that remains the question Eur Heart J 25 2004 2177 2179
26. E.J. Topol, R.M. Califf, and C.L. Grines A randomized trial of late reperfusion therapy for acute myocardial infarction Circulation 85 1992 2090 2099
27. V. Dzavik, D.S. Beanlands, and R.F. Davies Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (6 weeks) Q-wave acute myocardial infarction Am J Cardiol 73 1994 856 861
28. H. Horie, M. Takahashi, and K. Minai Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty Circulation 98 1998 2377 2382
29. Z.R. Yousef, S.R. Redwood, and C.A. Bucknall A randomized trial of delayed intervention after myocardial infarction: clinical end point and echocardiographic data from the Open Artery Trial Circulation 102 II Suppl 2000 II755
30. P.G. Steg, C. Thuaire, and D. Himbert DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction Eur Heart J 25 2004 2187 2194
31. U. Zeymer, A. Vogt, and R. Zahn Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention: results of the primary PCI registry of the ALKK Eur Heart J 25 2004 322 328
32. D.O. Williams, J. Borer, and E. Braunwald Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI Thrombolysis in Myocardial Infarction trial Circulation 73 1986 338 346
33. R.J. Peters, S.R. Mehta, and K.A. Fox Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes Circulation 108 2003 1682 1687
34. S.R. Steinhubl, P.B. Berger, and J.T. Mann III Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
35. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Implications of recent clinical trials for the National Cholesterol Program Adult Treatment Panel III Guidelines. NGC:3746. Available online at http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full. pdf.
36. ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction. Available online at http://www.acc.org/clinical/ guidelines/stemi/index.pdf.
37. Heart failure in adults. NGC:3514. Available online at http://www.guideline.gov/summary/summary.aspx?doc_id=4927&nbr= 3514&string=heart+AND+failure+AND+guideline+AND+ahrq.
38. S.A. Hunt, D.W. Baker, and M.H. Chin ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult Circulation 104 2001 2996 3007
39. V. Dzavik, R.G. Carere, and K.K. Teo An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) investigators Can J Cardiol 14 1998 825 832
40. G.A. Lamas, G.C. Flaker, and G. Mitchell Effect of infarct artery patency on prognosis after acute myocardial infarction Circulation 92 1995 1101 1109
41. R. Peto, M.C. Pike, and N. Armitage Design and analysis of randomized clinical trials requiring prolonged observation of each patient Br J Cancer 35 1977 1 39
42. D.A. Schoenfeld Sample size formula for the proportional hazards regression model Biometrics 39 1983 499 503
43. J.M. Lachin, and M.A. Foulkes Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification Biometrics 42 1986 507 519
44. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
45. B.W. Thompson, and G.L. Knatterud Interim monitoring plans to simultaneously evaluate a composite end point and a severe adverse event that is part of the composite end point Control Clin Trials 22 2001 32S
46. C.E. Bonferroni Il calcolo delle assicurazioni su gruppi di teste Studi in Onore del Professore Salvatore Ortu Carboni 1935 Italy Rome 13 60
47. K.K. Lan, and D.L. DeMets Discrete sequential boundaries for clinical trials Biometrika 70 1983 659
48. Reboussin DM, DeMets DL, Kim K, et al. Programs for computing group sequential bounds using the Lan-DeMets method. Technical report no. 60 University of Wisconsin Department of Biostatistics, Madison, 1992.
49. D.R. Cox Regression models and life tables J R Stat Soc 34 1972 187 220